Chopra Daveen — SEC insider filings
SEC reporting owner CIK 1740963. 42 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2021-05-06 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 22 filings — 129,935 shares, $11,078,278 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 76.
- Largest priced transaction: sale of 30,646 shares @ $90.99 ($2,788,547) in Edwards Lifesciences Corp, filed 2026-08-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edwards Lifesciences Corp (EW) | CVP, TMTT, Surgical & IHFM | 42 | — | 24 legs · 129,935 sh · $11,078,278 | 76 |
Insider filings — Chopra Daveen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 398 @ $86.77 | EDGAR |
| 2026-08-26 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 31,800 @ $72.68 · Sale (S): 1,154 @ $91.76 · Sale (S): 30,646 @ $90.99 · Option exercise (M): 31,800 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,500 @ $84.60 | EDGAR |
| 2026-05-12 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 13,583 @ $0 · Tax withholding (F): 7,538 @ $79.96 · Option exercise (M): 13,583 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 9,675 @ $0 · Tax withholding (F): 674 @ $83.20 · Tax withholding (F): 1,141 @ $82.76 · Grant/award (A): 49,100 (derivative) @ $0 · Grant/award (A): 9,675 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 282 @ $83.98 | EDGAR |
| 2025-12-11 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 2,000 @ $84.38 | EDGAR |
| 2025-09-15 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 3,205 @ $0 | EDGAR |
| 2025-08-25 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 2,500 @ $81.95 | EDGAR |
| 2025-05-22 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,500 @ $75.08 | EDGAR |
| 2025-05-12 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 580 @ $73.68 | EDGAR |
| 2025-05-09 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 627 @ $74.92 · Grant/award (A): 9,200 @ $0 · Grant/award (A): 47,000 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 291 @ $75.65 · Tax withholding (F): 289 @ $75.65 | EDGAR |
| 2024-12-06 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,750 @ $73.27 | EDGAR |
| 2024-08-20 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,250 @ $69.95 | EDGAR |
| 2024-05-13 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 821 @ $86.72 | EDGAR |
| 2024-05-09 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 7,000 @ $0 · Tax withholding (F): 447 @ $85.09 · Grant/award (A): 37,200 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 291 @ $85.06 · Option exercise (M): 4,713 @ $0 · Tax withholding (F): 2,321 @ $85.25 · Option exercise (M): 4,713 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,000 @ $59.26 · Sale (S): 1,200 @ $86.67 · Sale (S): 7,000 @ $86.75 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,000 @ $59.26 · Sale (S): 7,000 @ $78.25 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2023-12-06 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 3,500 @ $59.26 · Sale (S): 3,500 @ $70.00 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 8,500 @ $59.26 · Sale (S): 8,500 @ $70 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 8,500 @ $59.26 · Sale (S): 8,500 @ $76.07 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2023-08-29 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,500 @ $76.69 | EDGAR |
| 2023-05-15 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 6,475 @ $0 · Grant/award (A): 49,900 (derivative) @ $0 · Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2023-05-09 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 3,413 @ $0 · Tax withholding (F): 1,822 @ $88.74 · Tax withholding (F): 967 @ $88.74 · Option exercise (M): 3,413 (derivative) @ $0 | EDGAR |
| 2023-05-04 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 281 @ $87.81 · Tax withholding (F): 279 @ $88.10 | EDGAR |
| 2023-03-15 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,435 @ $45.28 · Sale (S): 4,435 @ $77.47 · Option exercise (M): 4,435 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,000 @ $45.28 · Sale (S): 4,000 @ $76.01 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2023-01-17 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,000 @ $45.28 · Sale (S): 4,000 @ $78 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,000 @ $45.28 · Sale (S): 4,000 @ $74.80 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2022-11-15 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,000 @ $45.28 · Sale (S): 4,000 @ $74.18 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 4,000 @ $45.28 · Sale (S): 4,000 @ $84.77 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,000 @ $102.49 | EDGAR |
| 2022-05-26 | 4 | Edwards Lifesciences Corp (EW) | Sale (S): 1,000 @ $98.31 | EDGAR |
| 2022-05-17 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,644 @ $95.93 | EDGAR |
| 2022-05-10 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 305 @ $100.52 · Option exercise (M): 8,531 @ $0 · Tax withholding (F): 4,469 @ $100.52 · Option exercise (M): 8,531 (derivative) @ $100.52 | EDGAR |
| 2022-05-05 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 3,250 @ $0 · Tax withholding (F): 279 @ $105.93 · Grant/award (A): 26,400 (derivative) @ $0 · Grant/award (A): 4,075 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 24,000 @ $45.28 · Sale (S): 24,000 @ $99.96 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2021-05-19 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,146 @ $89.49 | EDGAR |
| 2021-05-11 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 304 @ $91.75 | EDGAR |
| 2021-05-06 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 3,225 @ $0 · Grant/award (A): 28,000 (derivative) @ $0 · Grant/award (A): 4,025 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1740963 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs